While mutations in ENG and ACVRL1 are frequently identified in patients with HHT, negative results do not exclude the diagnosis, as a subset of patients with HHT do not carry detectable mutations [16]. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.